Details of the Drug
General Information of Drug (ID: DM9QTWB)
Drug Name |
1-Biphenyl-4-ylmaleimide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-(4-Biphenylyl)maleimide; MALEIMIDE, N-4-BIPHENYLYL-; BRN 0183921; 58609-75-9; AI3-02979; CHEMBL567545; 1-(4-phenylphenyl)pyrrole-2,5-dione; 1H-Pyrrole-2,5-dione, 1-(1,1'-biphenyl)-4-yl-; 1-Biphenyl-4-ylmaleimide; Cyto6B10; Maybridge3_004857; AC1L28LA; CBDivE_004932; 4-21-00-04634 (Beilstein Handbook Reference); SCHEMBL9719419; DTXSID30207328; MolPort-000-929-072; HMS1444M17; ZINC186459; STK003872; BDBM50300341; AKOS000296044; MCULE-5728148499; IDI1_016244; LS-88673
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 249.26 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||